Despite the wide phenotypic spectrum of POLRMT‐related mitochondrial disease, clinical symptoms of the newly reported patients confirm common features between affected individuals including predominant neurological manifestations such as motor developmental delay with impaired cognitive development affecting mainly speech and language and associated in several cases with behavioural problems. Here, POLRMT is linked to mitochondrial disease.